Total Payments
$13,141
2024 Payments
$100.63
Companies
54
Transactions
1,075
Medicare Patients
5,966
Medicare Billing
$212,720
Payment Breakdown by Category
Food & Beverage$13,086 (99.6%)
Education$54.67 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,086 | 1,067 | 99.6% |
| Education | $54.67 | 8 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,147 | 226 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,220 | 77 | $0 (2022) |
| GlaxoSmithKline, LLC. | $1,024 | 95 | $0 (2022) |
| PFIZER INC. | $847.27 | 64 | $0 (2022) |
| ABBVIE INC. | $818.09 | 61 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $807.56 | 80 | $0 (2022) |
| Lilly USA, LLC | $761.79 | 59 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $690.82 | 72 | $0 (2021) |
| Amarin Pharma Inc. | $658.06 | 46 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $582.87 | 44 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $100.63 | 8 | Novo Nordisk Inc ($63.50) |
| 2023 | $91.87 | 5 | Novo Nordisk Inc ($77.10) |
| 2022 | $1,721 | 129 | ABBVIE INC. ($355.69) |
| 2021 | $2,296 | 169 | PFIZER INC. ($361.65) |
| 2020 | $2,097 | 167 | Novo Nordisk Inc ($405.39) |
| 2019 | $2,418 | 222 | Novo Nordisk Inc ($434.74) |
| 2018 | $2,127 | 169 | AstraZeneca Pharmaceuticals LP ($349.07) |
| 2017 | $2,290 | 206 | Janssen Pharmaceuticals, Inc ($245.21) |
All Payment Transactions
1,075 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Obesity | ||||||
| 05/29/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 05/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Diabetes | ||||||
| 04/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Obesity | ||||||
| 02/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.66 | General |
| 01/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.86 | General |
| 11/08/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Obesity | ||||||
| 09/13/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Obesity | ||||||
| 02/16/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Obesity | ||||||
| 02/09/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Obesity | ||||||
| 12/15/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/30/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/29/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $10.04 | General |
| Category: PRIMARY CARE | ||||||
| 11/21/2022 | Novo Nordisk Inc | Wegovy (Drug), Saxenda | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: Obesity | ||||||
| 11/17/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Diabetes | ||||||
| 11/09/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Cardio-renal | ||||||
| 11/02/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 10/31/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $9.34 | General |
| Category: PRIMARY CARE | ||||||
| 10/27/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 32 | 1,961 | 2,737 | $158,294 | $70,951 |
| 2021 | 41 | 2,203 | 3,038 | $175,482 | $79,858 |
| 2020 | 35 | 1,802 | 2,299 | $142,093 | $61,911 |
Total Patients
5,966
Total Services
8,074
Medicare Billing
$212,720
Procedure Codes
108
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 173 | 173 | $30,275 | $21,743 | 71.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 109 | 172 | $20,340 | $10,441 | 51.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 123 | $20,469 | $8,500 | 41.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 52 | 52 | $5,432 | $3,561 | 65.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 185 | 277 | $6,925 | $2,881 | 41.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 66 | 76 | $5,700 | $2,580 | 45.3% |
| 94375 | Test to measure rate of airflow | Office | 2022 | 59 | 81 | $7,533 | $2,059 | 27.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 129 | 142 | $5,112 | $1,869 | 36.6% |
| G0238 | Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring) | Office | 2022 | 94 | 275 | $9,075 | $1,810 | 19.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 56 | 56 | $1,792 | $1,566 | 87.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 140 | 184 | $2,944 | $1,406 | 47.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 56 | 78 | $2,730 | $1,295 | 47.4% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2022 | 51 | 74 | $5,550 | $1,239 | 22.3% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2022 | 58 | 58 | $2,552 | $1,106 | 43.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 63 | 112 | $2,576 | $1,074 | 41.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 39 | 39 | $4,290 | $1,068 | 24.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 200 | 358 | $4,354 | $1,057 | 24.3% |
| 82670 | Measurement of total estradiol (hormone) | Office | 2022 | 24 | 31 | $3,782 | $831.77 | 22.0% |
| 82306 | Vitamin d-3 level | Office | 2022 | 26 | 26 | $1,820 | $759.83 | 41.7% |
| 84403 | Testosterone (hormone) level, total | Office | 2022 | 20 | 29 | $1,595 | $739.65 | 46.4% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 52 | 73 | $1,606 | $650.99 | 40.5% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2022 | 16 | 24 | $1,056 | $435.47 | 41.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 15 | 15 | $2,100 | $383.83 | 18.3% |
| 83721 | Ldl cholesterol level | Office | 2022 | 24 | 26 | $884.00 | $270.55 | 30.6% |
| 94664 | Evaluation of use of breathing device | Office | 2022 | 19 | 19 | $570.00 | $237.32 | 41.6% |
About Dr. Joseph Jacko, MD
Dr. Joseph Jacko, MD is a Internal Medicine healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730185844.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Jacko, MD has received a total of $13,141 in payments from pharmaceutical and medical device companies, with $100.63 received in 2024. These payments were reported across 1,075 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($13,086).
As a Medicare-enrolled provider, Jacko has provided services to 5,966 Medicare beneficiaries, totaling 8,074 services with total Medicare billing of $212,720. Data is available for 3 years (2020–2022), covering 108 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Sports Medicine
- Location Columbus, OH
- Active Since 06/23/2005
- Last Updated 07/30/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730185844
Products in Payments
- Ozempic (Drug) $934.06
- FARXIGA (Drug) $663.08
- Vascepa (Drug) $658.06
- XARELTO (Drug) $622.89
- TRELEGY ELLIPTA (Drug) $559.48
- JANUVIA (Drug) $535.85
- ELIQUIS (Drug) $532.90
- JARDIANCE (Drug) $449.78
- Tresiba (Drug) $435.73
- NURTEC ODT (Drug) $359.83
- TRULICITY (Drug) $337.11
- SYMBICORT (Drug) $305.74
- VRAYLAR (Drug) $285.73
- VESICARE (Drug) $249.56
- QULIPTA (Drug) $238.86
- COLOGUARD DNA CAPTURE REAGENTS (Device) $237.85
- Myrbetriq (Drug) $230.06
- UBRELVY (Drug) $215.72
- ANORO (Drug) $194.41
- INVOKANA (Drug) $184.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Columbus
Anish Amin, M.d, M.D
Internal Medicine — Payments: $807,022
Internal Medicine $807,022
Dr. Alexa Meara, Md, MD
Internal Medicine — Payments: $377,655
Internal Medicine $377,655
Jayanta Mukherjee, Md, MD
Internal Medicine — Payments: $240,062
Internal Medicine $240,062
Dr. David Lo, M.d, M.D
Internal Medicine — Payments: $185,475
Internal Medicine $185,475
Narendranath Epperla, Md, MD
Internal Medicine — Payments: $184,240
Internal Medicine $184,240
Lucy Laperna, Do, DO
Internal Medicine — Payments: $133,632
Internal Medicine $133,632